ArticleCureus2025
Flow Diverter Stents for the Endovascular Treatment of Ruptured Intracranial Aneurysms: An Analysis of a Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective This study aimed to describe the clinical outcomes, complications, and aneurysm occlusion of patients with aneurysmal subarachnoid hemorrhage treated with a flow diverter in our institute. Methods This is a retrospective study of the clinical and imaging characteristics in patients with aneurysmal subarachnoid hemorrhage treated by endovascular approach using a flow diverter device from January 2019 to May 2024 at the Specialty Hospital, La Raza National Medical Center, Mexico. The information was obtained through the analysis of clinical records and imaging. Imaging controls were obtained through digital subtraction angiography (DSA) and/or CT angiography (CTA) performed during the 12 months post-treatment. For statistical analysis, IBM SPSS Statistics for Windows, Version 25.0 (IBM Corp., Armonk, New York, United States), was used, with normality assessed using the Shapiro-Wilk test. Data were expressed as absolute frequencies, percentages, mean, and standard deviation. Additionally, the results are presented in descriptive tables for each patient. Results Fifteen patients were analyzed, of whom 73.3% were women and 26.7% were men. No patient experienced rebleeding or died during the 12-month follow-up period. On the 12-month follow-up imaging studies, 14 patients (93.3%) showed complete aneurysm occlusion. Three patients (20%) presented parent vessel occlusion associated with the flow diverter. Thirteen patients (86.7%) had a favorable functional outcome (modified Rankin scale (mRS) 0-2). Conclusions The use of flow diverters in patients with ruptured intracranial aneurysms can be considered an effective and viable alternative in carefully selected cases. Prospective studies with larger sample sizes are needed to evaluate their efficacy and safety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.